|
CHURC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89138999999727E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.97559999999664E-05 |
| Normal-vs-Stage2 |
6.815600E-02 |
| Normal-vs-Stage3 |
1.362090E-04 |
| Normal-vs-Stage4 |
6.44459996479441E-09 |
| Stage1-vs-Stage2 |
1.513770E-01 |
| Stage1-vs-Stage3 |
7.572200E-01 |
| Stage1-vs-Stage4 |
2.356000E-03 |
| Stage2-vs-Stage3 |
1.467430E-01 |
| Stage2-vs-Stage4 |
2.217100E-03 |
| Stage3-vs-Stage4 |
1.799530E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.04609999999916E-05 |
| Normal-vs-AfricanAmerican |
5.298100E-02 |
| Normal-vs-Asian |
1.90566999999087E-05 |
| Caucasian-vs-AfricanAmerican |
3.612800E-01 |
| Caucasian-vs-Asian |
2.863800E-01 |
| AfricanAmerican-vs-Asian |
1.037180E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.9835000004439E-07 |
| Normal-vs-Female |
1.396580E-04 |
| Male-vs-Female |
7.285500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.045710E-04 |
| Normal-vs-Age(41-60Yrs) |
2.217900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.66809999999829E-05 |
| Normal-vs-Age(81-100Yrs) |
1.373650E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.520800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.806200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.888000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.302000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.352400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.733000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.512100E-02 |
| Classical-VS-Follicular |
4.688200E-01 |
| Classical-VS-Other |
3.458800E-01 |
| Classical-VS-Normal |
2.040000E-04 |
| Tall-VS-Follicular |
2.763600E-01 |
| Tall-VS-Other |
9.745800E-01 |
| Tall-VS-Normal |
4.07550000000034E-05 |
| Follicular-VS-Other |
5.472000E-01 |
| Follicular-VS-Normal |
5.974700E-04 |
| Other-VS-Normal |
1.802160E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.805720E-04 |
| Normal-vs-N1 |
6.71140000241266E-08 |
| N0-vs-N1 |
2.145500E-02 |
|
|
